ARWR
insider transactionsARROWHEAD PHARMACEUTICALS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-26.1K
0 buy · 26.1K sell
Net value · 90d
-$1.9M
$0 in · $1.9M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
5
0 buy · 26.1K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
11.9K sh
Own New
-
Sell·S
Director · 10b5-1
$228.3K
3.0K sh · $76.88
Own -5%
-
Sell·S
Chief Medical Officer · 10b5-1
$750.0K
10.0K sh · $75.00
Own -4%
-
Sell·S
Chief Financial Officer · 10b5-1
$627.9K
8.7K sh · $71.92
Own -5%
-
Sell·S
Chief Financial Officer · 10b5-1
$81.5K
1.2K sh · $70.45
Own -1%
-
Sell·S
Chief Financial Officer · 10b5-1
$224.9K
3.2K sh · $70.11
Own -2%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Matthew Gregory Cohen | Grant A | 11.9K | $0 |
| May 12, 2026 | Hongbo Lu 10b5-1 | Sell S | 3.0K | $228.3K |
| Apr 23, 2026 | James C Hamilton 10b5-1 | Sell S | 10.0K | $750.0K |
| Apr 22, 2026 | Daniel Joseph Apel KEY 10b5-1 | Sell S | 8.7K | $627.9K |
| Apr 22, 2026 | Daniel Joseph Apel KEY 10b5-1 | Sell S | 1.2K | $81.5K |
| Apr 22, 2026 | Daniel Joseph Apel KEY 10b5-1 | Sell S | 3.2K | $224.9K |
About ARWR insider trading
This page tracks insider transactions for ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.